Impact Factor
2.54
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.52
104 total citations
h5-index
20
h5 depth signal
Cited share
42.0%
29 of 69
Total citations
104
Citation footprint
Metric signal
1.06
External metric anchor
Self-citation
4.8%
5 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Japan
230
United States
61
China
39
Iran
23
Brazil
16
Citing Fields of Research
Immunotherapy
271
Immunology
208
Cell Biology
97
Epithelial Barriers
63
Virology
46
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
745
Articles tracked across the journal lifetime
Indexed publication set
69
29 cited publications
Last 12 months
19
1.9 publications/month
Open access share
0.0%
0 OA publications in the last year
Leading citing country
Japan
230 citing publications
Leading citing field
Immunotherapy
271 citing publications
Latest tracked publication
28 September 2026
10 recent records available
Coverage & Indexing History
v32n1, Feb. 2013-
v32n1, Feb. 2013-
Research Focus & Classification
Indexed Subjects
Immunotherapy
Immunology
Cell Biology
Fungal Pathogenesis
Hematology
Broad Categories
Allergy and Immunology
Cell Biology
Clinical Laboratory Techniques
Immunotherapy
Hematology
Immunology
Cellular Membrane Transporters & Receptors
Endocrinology & Metabolism
Separation Techniques
MeSH Descriptors
Antibodies, Monoclonal
Immunologic Tests
Immunotherapy
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1177/21679436261494899
Open DOI
Restoring Trust in Commercial Antibody Validation
02
DOI 10.1177/21679436261483330
Open DOI
Recombinant Expression and Engineering of MDI- and HDI-Specific Monoclonal Antibodies for Proof-of-Concept Detection of Diisocyanate Adducts and Candidate Assay Calibrators
Methylene-diphenyl diisocyanate (MDI) and hexamethylene diisocyanate (HDI), important chemicals for polyurethane production, can react with self-molecules, trigger immune responses, and cause asthma. To validate molecular determinants of...
03
DOI 10.1177/21679436261476438
Open DOI
Monoclonal Antibody-Based Anti-Cryptococcosis Therapy
Cryptococcosis remains one of the most severe invasive fungal diseases worldwide, causing high morbidity and mortality, particularly among immunocompromised individuals. Despite the availability of antifungal drugs, current therapeutic r...
04
DOI 10.1177/21679436261464851
Open DOI
A Novel Anti-Glypican-3 Monoclonal Antibody G 3 Mab-25 for Versatile Applications
Glypican-3 (GPC3) belongs to the glypican family of heparan sulfate proteoglycans and is frequently overexpressed in hepatocellular carcinoma (HCC). The overexpression of GPC3 is associated with the poor clinical outcomes, suggesting its...
05
DOI 10.1177/21679436261461702
Open DOI
Epitope Mapping of Anti-mouse ACKR4 Monoclonal Antibodies Developed by N-Terminal Peptide Immunization
Leukocyte migration is a fundamental process in both innate and adaptive immune responses. This process is tightly regulated by chemokines and their cognate receptors. The bioavailability of chemokines is further modulated by atypical ch...
06
DOI 10.1177/21679436261459606
Open DOI
Epitope Mapping of Anti-Mouse C-C Motif Chemokine Receptor 1 Monoclonal Antibodies Developed by the Cell-Based Immunization and Screening Method
The C-C motif chemokine receptor 1 (CCR1) plays key roles in guiding leukocyte movement during immune surveillance and inflammatory responses. Targeting CCR1 is a promising approach for treating autoimmune diseases and cancers. We previo...
07
DOI 10.1177/21679436261458597
Open DOI
Guidelines for Reporting New Monoclonal Antibodies: Improving Transparency, Reproducibility, and Research Utility
08
DOI 10.1177/21679436261450334
Open DOI
Establishment of a Novel Anti-EphA4 Monoclonal Antibody, Ea 4 Mab-3, for Versatile Applications
Erythropoietin-producing hepatocellular carcinoma (Eph) receptor A4 (EphA4) binds to a broad range of ephrin ligands and is upregulated in various tumors. EphA4 activation plays crucial roles in the maintenance of cancer invasiveness, im...
09
DOI 10.1177/21679436261431081
Open DOI
Acknowledgment of Reviewers 2025
10
DOI 10.1177/21679436261441142
Open DOI
A Novel Anti-CDH5/VE-Cadherin Monoclonal Antibody (Ca 5 Mab-8) for Flow Cytometry, Western Blotting, and Immunohistochemistry
Cadherin-5 (CDH5), also known as vascular endothelial cadherin (VE-cadherin), plays crucial roles in endothelial cell adhesion, vascular barrier function, and signaling. CDH5 manages endothelial cell–cell junctions during vascular remode...